Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Bristol-Myers Squibb Company BMY
$67.96
-$1.1 (-1.62%)
На 18:00, 12 мая 2023
+12.57%
Потенциал через год
Ранг: 1
Ключевые показатели
-
Marketcap
142731752261.00000000
-
week52high
81.44
-
week52low
65.28
-
Revenue
46159000000
-
P/E TTM
59
-
Beta
0.43321700
-
EPS
3.43000000
-
Last Dividend
2.28000000
-
Next Earnings Date
27 июл 2023 г. в 12:00
Описание компании
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for the treatment of DVT/PE; Opdivo for anti-cancer indications; Pomalyst/Imnovid indicated for patients with multiple myeloma; and Orencia for adult patients with active RA and psoriatic arthritis. It also provides Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy for the treatment of patients with unresectable or metastatic melanoma; Abraxane, a protein-bound chemotherapy product; Reblozyl for the treatment of anemia in adult patients with beta thalassemia; and Empliciti for the treatment of multiple myeloma. In addition, the company offers Zeposia to treat relapsing forms of multiple sclerosis; Breyanzi, a CD19-directed genetically modified autologous T cell immunotherapy for the treatment of adult patients with relapsed or refractory large B-cell lymphoma; Inrebic, an oral kinase inhibitor indicated for the treatment of adult patients with myelofibrosis; and Onureg for the treatment of adult patients with AML. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. The company was founded in 1887 and is headquartered in New York, New York.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| UBS | Neutral | Neutral | 28 июл 2022 г. |
| Morgan Stanley | Underweight | Underweight | 28 июл 2022 г. |
| Atlantic Equities | Overweight | Overweight | 28 июл 2022 г. |
| Raymond James | Market Perform | Outperform | 06 июн 2022 г. |
| Raymond James | Market Perform | Outperform | 03 июн 2022 г. |
| Berenberg | Hold | Buy | 14 сент 2022 г. |
| BMO Capital | Outperform | Outperform | 12 сент 2022 г. |
| Atlantic Equities | Overweight | Overweight | 12 сент 2022 г. |
| Barclays | Equal-Weight | Equal-Weight | 12 окт 2022 г. |
| Guggenheim | Neutral | Buy | 10 окт 2022 г. |
| Morgan Stanley | Underweight | Underweight | 27 окт 2022 г. |
| Atlantic Equities | Overweight | Overweight | 27 окт 2022 г. |
| Atlantic Equities | Overweight | Overweight | 10 ноя 2022 г. |
| Credit Suisse | Neutral | 18 ноя 2022 г. | |
| Wells Fargo | Equal-Weight | Equal-Weight | 03 янв 2023 г. |
| Cantor Fitzgerald | Overweight | 17 янв 2023 г. | |
| Morgan Stanley | Underweight | Underweight | 03 февр 2023 г. |
| Atlantic Equities | Overweight | Overweight | 03 февр 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Покожие компании
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Bhatt Deepak | A | 4815 | 2808 | 01 февр 2023 г. |
| Rice Derica W | A | 15497 | 2808 | 01 февр 2023 г. |
| Price Paula A | A | 11309 | 2808 | 01 февр 2023 г. |
| Arduini Peter J | A | 43617 | 2808 | 01 февр 2023 г. |
| Hidalgo Medina Manuel | A | 8769 | 2808 | 01 февр 2023 г. |
| YALE PHYLLIS R | A | 19509 | 2808 | 01 февр 2023 г. |
| Vousden Karen H | A | 24861 | 2808 | 01 февр 2023 г. |
| Meyers Gregory Scott | D | 7629 | 2543 | 01 февр 2023 г. |
| Meyers Gregory Scott | D | 1812 | 731 | 01 февр 2023 г. |
| Meyers Gregory Scott | A | 2543 | 2543 | 01 февр 2023 г. |
Institutional Ownership
Institutional Ownership
| Holder | Shares | Change | Date Reported |
|---|---|---|---|
| DIMENSIONAL FUND ADVISORS LP | 14659982 | 155845 | 30 сент 2022 г. |
| Vanguard Total Stock Market Index Fund | 63771200 | -564465 | 31 авг 2020 г. |
| Vanguard 500 Index Fund | 46493100 | -169252 | 31 авг 2020 г. |
| SPDR S&P 500 ETF | 23864800 | -113129 | 31 авг 2020 г. |
| US Bank Vanguard Institutional 500 Index Trust | 19439900 | -90158 | 31 авг 2020 г. |
| iShares Core S&P 500 ETF | 17119800 | -93024 | 31 авг 2020 г. |
| Vanguard Dividend Appreciation Index Fund | 15355800 | 59429 | 31 авг 2020 г. |
| Fidelity 500 Index Fund | 20154800 | -21814 | 31 июл 2020 г. |
| Vanguard Health Care Fund | 35182000 | -1936730 | 30 июн 2020 г. |
| Dodge & Cox Stock Fund | 16694000 | -4269200 | 30 июн 2020 г. |
Новостная лента
Is Bristol-Myers Squibb Stock a Buy Now?
The Motley Fool
11 мая 2023 г. в 09:17
Bristol-Myers Squibb's stock hasn't been doing well of late, as investors have been discounting it. The company's lack of growth and high debt load hasn't made it an attractive buy.
3 Things About Bristol-Myers Squibb That Smart Investors Know
The Motley Fool
10 мая 2023 г. в 08:45
Bristol-Myers is now in a period of relatively less output from its late-stage pipeline. It's going to acquire businesses and make collaboration deals to ameliorate that.
Which Is the Better Passive Income Stock, Eli Lilly or Bristol Myers Squibb?
The Motley Fool
05 мая 2023 г. в 10:15
There are often trade-offs to make when selecting passive income stocks. Eli Lilly's next couple of years will see its revenue burgeon by billions.
Should Income Investors Buy This Blue Chip Dividend Stock?
The Motley Fool
05 мая 2023 г. в 10:00
Bristol Myers Squibb grew its profits in the first quarter. The company's generous dividend appears to be sustainable.
Best Dividend Stocks To Buy In 2023? 2 To Know
Stockmarketcom
04 мая 2023 г. в 06:54
Dividend stocks to watch in the stock market today.